Published in Obesity and Diabetes Week, September 12th, 2005
Medtronic recorded first quarter fiscal year 2006 revenues of $2.690 billion, a 15% increase over the $2.346 billion recorded in the first quarter of fiscal year 2005.
Reflecting the weaker dollar, foreign currency translation had a positive effect on first quarter revenues of $26.0 million compared to the prior year first quarter. Before purchased in-process research and development (IPR&D) charges, first quarter net earnings of $615.9 million, or $0.50 per diluted share, increased 16% over net earnings of $529.7 million and $0.43 per...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.